The risk analysis index as a predictor of 30-day mortality for elderly obese patients undergoing elective total joint arthroplasty

风险分析指数作为老年肥胖患者择期全关节置换术30天死亡率的预测指标

阅读:2

Abstract

INTRODUCTION: The older population of the United States of America is continuing to increase, leading to rising rates of degenerative joint disease. Combined with the high prevalence of obesity in the US, orthopaedic surgeons are performing record numbers of elective total joint arthroplasty (TJA) procedures in higher risk patients. As age and obesity are risk factors for mortality following TJA, preoperative risk stratification tools such as frailty may be used to optimize surgical candidate selection to mitigate adverse outcomes. METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was queried for patients ≥65 years of age with a BMI of ≥30 kg/m(2) who underwent elective primary total knee or total hip arthroplasty for degenerative joint disease. Frailty was measured using the 5-item Modified Frailty Index (mFI-5) and the Risk Analysis Index (RAI). Multivariate regression was performed to evaluate predictive value of frailty and discriminatory accuracy was quantified using receiver operating characteristic (ROC) analysis. RESULTS: There were 169,065 patients who met the inclusion criteria from 2015 to 2019. The median age was 71 years, 60.8 % were women and 72.6 % were White. Increasing frailty predicted greater mortality as measured by the RAI and mFI-5. Further, the RAI had superior discrimination compared to the mFI-5 when quantified using ROC analysis. DISCUSSION: Frailty as measured by the RAI has superior clinical applicability, predictive value and discrimination for identifying patients at risk of mortality following TJA in an older obese population. Given this, orthopaedic surgeons may use the RAI as a tool for optimizing candidate selection and identifying high risk patients preoperatively.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。